Unlike the clinics and medical spas targeted by Novo, Hims does reveal that the drugs it sells are not FDA approved but in one ad seen by a Hunterbrook Media reporter, it does so only in barely visible font that blends into the background of its ads
The Incretin Landscape in 2026 The incretin-based therapeutics field has undergone rapid evolution since the approval of exenatide in 2005
Talk to your doctor before considering semaglutide tablets for weight loss or switching to compounded versions
Patients with commercial insurance that covers Wegovy can pay as little as ~$25/month using the Wegovy Savings Card (maximum savings of ~$100 per monthly fill)
Weight loss above 15%, seen with Novos Wegovy (at 68 weeks), is the minimum bar
Effect of 6-Week Course of Glucagon-Like Peptide 1 on Glycaemic Control, Insulin Sensitivity, and Beta-Cell Function in Type 2 Diabetes: A Parallel-Group Study